Aspirin and cancer risk: a quantitative review to 2011

2012/04/20 by C. Bosetti, Cristina Bosetti, V. Rosato +7 · 4 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Antiplatelet Therapy and Cardiovascular Diseases #Cancer, Lipids, and Metabolism #Inflammatory mediators and NSAID effects

paper · pdf · doi:10.1093/annonc/mds113

openalex publication_date 2012/04/20 · crossref created 2012/04/20 · crossref issued 2012/06/01 · crossref published 2012/06/01 · crossref published-print 2012/06/01 · crossref deposited 2023/06/22 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/04 · crossref indexed 2026/08/04

Citations

• Quantifying heterogeneity in a meta‐analysis
• Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

Cited by

• Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: A systematic review and meta-analysis of observational studies
• Estimates of benefits and harms of prophylactic use of aspirin in the general population
• Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019
• Aspirin [wikipedia]